Royce & Associates LP
13F filer · CIK 0000906304Reported Aug 14, 2026
13F portfolio value$12.4BU.S. long equity reported on 13F
Positions741Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight9.1%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 2026741 positions | |||||
| $144M | 1.16% | 2.02% | -20.7% | Q4 2018 | |
| $137M | 1.10% | 5.00% | +4.4% | Q2 2013 | |
| $116M | 0.94% | 0.39% | -35.2% | Q2 2013 | |
| $114M | 0.92% | 1.52% | -0.2% | Q2 2013 | |
| $112M | 0.91% | 2.78% | +33.7% | Q2 2013 | |
| $109M | 0.88% | 0.75% | Not reported | Q2 2016 | |
| $108M | 0.87% | 0.58% | -9.8% | Q4 2019 | |
| $96.7M | 0.78% | 2.70% | +5.0% | Q2 2013 | |
| $95M | 0.77% | 1.47% | -12.3% | Q2 2013 | |
| $92.2M | 0.74% | 0.79% | -1.7% | Q1 2019 | |
| $92.1M | 0.74% | 0.88% | +5.4% | Q2 2013 | |
| $91.8M | 0.74% | 1.01% | -23.3% | Q1 2020 | |
| $86M | 0.69% | 7.67% | +2.0% | Q2 2021 | |
| $85.4M | 0.69% | 1.42% | +6.4% | Q2 2022 | |
| $84.9M | 0.68% | 2.41% | +8.0% | Q2 2013 | |
| $83.5M | 0.67% | 2.25% | +11.7% | Q2 2013 | |
| $82.8M | 0.67% | 2.21% | +8.7% | Q2 2013 | |
| $80.4M | 0.65% | 1.01% | -10.2% | Q2 2020 | |
| $77.7M | 0.63% | 2.73% | +15.6% | Q2 2013 | |
| $76.4M | 0.62% | 1.44% | +1.8% | Q3 2015 | |
| $75.7M | 0.61% | 1.50% | +6.0% | Q2 2020 | |
| $74.7M | 0.60% | 1.49% | -0.1% | Q2 2020 | |
| $73.2M | 0.59% | 0.35% | -8.3% | Q2 2013 | |
| INGVTIngevity Corp | $70.2M | 0.57% | 2.73% | +6.4% | Q1 2017 |
| $69.3M | 0.56% | 1.86% | -53.7% | Q2 2013 | |
| $68.7M | 0.55% | 2.67% | +6.4% | Q1 2017 | |
| $68.3M | 0.55% | 1.63% | -28.4% | Q4 2016 | |
| $67.7M | 0.55% | 1.52% | -11.3% | Q2 2024 | |
| $67M | 0.54% | 1.24% | +31.2% | Q2 2013 | |
| $66.3M | 0.53% | 1.02% | +2.1% | Q4 2015 | |
| $63.6M | 0.51% | 0.53% | -14.7% | Q2 2013 | |
| $63.4M | 0.51% | 2.25% | -7.0% | Q2 2013 | |
| $63.3M | 0.51% | 0.56% | -7.1% | Q2 2013 | |
| $61.5M | 0.50% | 0.53% | -37.7% | Q2 2013 | |
| $60M | 0.48% | 0.80% | -19.7% | Q2 2013 | |
| $59M | 0.48% | 0.88% | +190.4% | Q1 2014 | |
| $58.1M | 0.47% | 0.67% | -3.0% | Q2 2013 | |
| $56.8M | 0.46% | 0.26% | -2.6% | Q2 2023 | |
| $55.8M | 0.45% | 0.51% | +4.0% | Q4 2014 | |
| $55.3M | 0.44% | 3.81% | -0.5% | Q2 2013 | |
| $55M | 0.44% | 3.29% | +4.5% | Q2 2013 | |
| $55M | 0.44% | 1.55% | -26.7% | Q1 2014 | |
| $53.5M | 0.43% | 2.45% | +7.8% | Q2 2013 | |
| $52.5M | 0.42% | 1.55% | -5.7% | Q2 2013 | |
| $51.2M | 0.41% | 2.17% | +16.3% | Q2 2013 | |
| $51.1M | 0.41% | 1.75% | +4.2% | Q3 2022 | |
| $50.9M | 0.41% | 1.24% | -14.3% | Q4 2013 | |
| $50.7M | 0.41% | 1.22% | +28.0% | Q2 2023 | |
| $49M | 0.39% | 0.90% | -4.0% | Q2 2016 | |
| $48.9M | 0.39% | 0.47% | -18.5% | Q2 2013 | |
| Q1 2026Reported May 12, 2026768 positions | |||||
| $133M | 1.31% | 2.55% | +1.5% | Q4 2018 | |
| $102M | 1.01% | 4.74% | +9.0% | Q2 2013 | |
| $101M | 1.00% | 1.52% | +18.2% | Q2 2013 | |
| $96.2M | 0.95% | 1.32% | -5.7% | Q1 2020 | |
| $92.8M | 0.92% | 0.60% | -34.5% | Q2 2013 | |
| $80M | 0.79% | 2.20% | -0.1% | Q2 2013 | |
| $78.6M | 0.78% | 1.34% | -9.4% | Q2 2022 | |
| $78.2M | 0.77% | 0.83% | +9.9% | Q2 2013 | |
| $78.1M | 0.77% | 7.53% | +2.3% | Q2 2021 | |
| $75.9M | 0.75% | 1.46% | +2.2% | Q2 2020 | |
| $75M | 0.74% | 2.51% | -6.6% | Q1 2017 | |
| $74.8M | 0.74% | 2.57% | +20.5% | Q2 2013 | |
| $74.7M | 0.74% | 2.32% | +75.6% | Q2 2013 | |
| $73.6M | 0.73% | 0.86% | -6.7% | Q2 2013 | |
| $72.8M | 0.72% | 0.99% | -24.7% | Q2 2013 | |
| $71M | 0.70% | 0.75% | -13.0% | Q2 2016 | |
| $69.6M | 0.69% | 2.02% | +16.1% | Q2 2013 | |
| $67.3M | 0.66% | 0.38% | -6.9% | Q2 2013 | |
| $67.1M | 0.66% | 0.81% | -16.7% | Q1 2019 | |
| $65M | 0.64% | 0.64% | -13.3% | Q4 2019 | |
| $64.6M | 0.64% | 2.04% | -17.2% | Q2 2013 | |
| $64.4M | 0.64% | 2.05% | +23.6% | Q2 2013 | |
| $63.4M | 0.63% | 1.00% | +22.5% | Q4 2015 | |
| INGVTIngevity Corp | $62.9M | 0.62% | 2.53% | -20.5% | Q1 2017 |
| $62.1M | 0.61% | 4.04% | +5.7% | Q2 2013 | |
| $60.8M | 0.60% | 1.42% | +4.1% | Q2 2020 | |
| $59.6M | 0.59% | 1.12% | -8.1% | Q2 2020 | |
| $58.8M | 0.58% | 1.62% | -9.6% | Q3 2022 | |
| $58.1M | 0.57% | 1.58% | -34.7% | Q2 2020 | |
| $55.8M | 0.55% | 1.72% | -0.6% | Q2 2024 | |
| $52.6M | 0.52% | 1.61% | +31.4% | Q2 2013 | |
| $52M | 0.51% | Not reported | -13.5% | Q2 2013 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $51.7M | 0.51% | 1.71% | +9.4% | Q4 2019 |
| $50.4M | 0.50% | 0.62% | -2.6% | Q2 2013 | |
| $49.3M | 0.49% | 2.31% | +11.8% | Q3 2015 | |
| $49.3M | 0.49% | 0.94% | +47.4% | Q2 2013 | |
| $49.1M | 0.48% | 0.69% | -1.8% | Q2 2013 | |
| $48M | 0.47% | 0.27% | +19.0% | Q2 2023 | |
| $47.4M | 0.47% | 2.27% | -1.4% | Q2 2013 | |
| $47.2M | 0.47% | 1.70% | -30.9% | Q2 2013 | |
| $47.1M | 0.47% | 0.60% | -24.3% | Q2 2013 | |
| $46.4M | 0.46% | 2.11% | -2.4% | Q1 2014 | |
| $45.6M | 0.45% | 0.24% | -16.3% | Q2 2013 | |
| $45.3M | 0.45% | 1.05% | +10.5% | Q3 2015 | |
| $45.2M | 0.45% | 0.90% | +14.3% | Q4 2020 | |
| $45.2M | 0.45% | 1.43% | +13.1% | Q4 2013 | |
| $45.1M | 0.45% | 6.58% | +57.3% | Q2 2019 | |
| $44.2M | 0.44% | 0.95% | +16.5% | Q2 2023 | |
| $44.1M | 0.44% | 0.93% | +17.9% | Q2 2016 | |
| $43.9M | 0.43% | 2.42% | -1.8% | Q2 2013 | |
| Q4 2025Reported Feb 9, 2026753 positions | |||||
| $131M | 1.33% | 2.52% | -2.6% | Q4 2018 | |
| $104M | 1.05% | 4.36% | +19.2% | Q2 2013 | |
| $101M | 1.02% | 1.29% | +4.4% | Q2 2013 | |
| $100M | 1.02% | 1.48% | +14.3% | Q2 2022 | |
| $98.5M | 1.00% | 0.92% | -25.5% | Q2 2013 | |
| $88.4M | 0.90% | 2.18% | -5.1% | Q2 2013 | |
| $79.2M | 0.80% | 2.70% | -2.8% | Q1 2017 | |
| $79.2M | 0.80% | 1.31% | -6.4% | Q2 2013 | |
| $79.1M | 0.80% | 7.36% | -0.7% | Q2 2021 | |
| $74.3M | 0.75% | 0.74% | +0.3% | Q2 2013 | |
| $73.4M | 0.74% | 1.42% | +5.0% | Q2 2020 | |
| $70.9M | 0.72% | 1.40% | -0.2% | Q1 2020 | |
| $66.7M | 0.68% | 0.86% | -2.9% | Q2 2016 | |
| INGVTIngevity Corp | $65.8M | 0.67% | 3.13% | +7.7% | Q1 2017 |
| $64.6M | 0.65% | 1.49% | -21.2% | Q2 2013 | |
| $62.7M | 0.64% | 0.79% | -9.1% | Q2 2013 | |
| $61.5M | 0.62% | 1.64% | +0.3% | Q2 2013 | |
| $61.1M | 0.62% | 2.42% | -6.1% | Q2 2020 | |
| $59.7M | 0.61% | 0.41% | +0.6% | Q2 2013 | |
| $58.9M | 0.60% | 0.97% | -11.9% | Q1 2019 | |
| $58.7M | 0.60% | 0.93% | -4.1% | Q2 2013 | |
| $58.4M | 0.59% | 1.74% | +30.8% | Q2 2013 | |
| $58.1M | 0.59% | 2.46% | +30.5% | Q2 2013 | |
| $58M | 0.59% | Not reported | +9.9% | Q2 2013 | |
| $58M | 0.59% | 0.82% | +3.5% | Q4 2015 | |
| $58M | 0.59% | 2.13% | +42.0% | Q2 2013 | |
| $57.7M | 0.59% | 0.75% | +19.0% | Q4 2019 | |
| $57.6M | 0.58% | 1.73% | -13.4% | Q3 2022 | |
| $56.3M | 0.57% | 0.95% | +0.6% | Q3 2015 | |
| $55.4M | 0.56% | 1.23% | +7.6% | Q2 2020 | |
| $51.9M | 0.53% | 9.74% | +2.4% | Q2 2013 | |
| $50.9M | 0.52% | 0.84% | +10.8% | Q3 2022 | |
| $50.4M | 0.51% | 1.36% | +33.2% | Q2 2020 | |
| $48.5M | 0.49% | 1.47% | -12.8% | Q2 2013 | |
| $48.4M | 0.49% | 1.73% | -11.2% | Q2 2024 | |
| $47.3M | 0.48% | 0.29% | -3.9% | Q2 2013 | |
| $47M | 0.48% | 0.71% | +11.7% | Q2 2013 | |
| $46.7M | 0.47% | 2.34% | -4.6% | Q2 2013 | |
| $45.3M | 0.46% | 1.31% | +73.8% | Q2 2013 | |
| $44.6M | 0.45% | 3.85% | +0.4% | Q2 2013 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $44.6M | 0.45% | 1.56% | -6.1% | Q4 2019 |
| $44.3M | 0.45% | 2.08% | -10.2% | Q3 2015 | |
| $43.8M | 0.44% | 3.29% | -20.0% | Q2 2013 | |
| $43.5M | 0.44% | 0.80% | +6.1% | Q2 2013 | |
| $43.4M | 0.44% | 0.85% | +2.3% | Q2 2013 | |
| $43.3M | 0.44% | 0.23% | -5.4% | Q2 2023 | |
| $42.9M | 0.43% | 1.80% | -16.2% | Q2 2013 | |
| $42M | 0.43% | 1.28% | -5.7% | Q2 2013 | |
| $42M | 0.43% | 1.22% | -3.9% | Q2 2013 | |
| $41.8M | 0.42% | 1.25% | +5.3% | Q4 2013 | |
| Q3 2025Reported Nov 12, 2025752 positions | |||||
| $119M | 1.18% | 2.58% | +0.4% | Q4 2018 | |
| $102M | 1.02% | 1.23% | -9.6% | Q2 2013 | |
| $89.9M | 0.90% | 1.23% | -7.9% | Q2 2013 | |
| $89.5M | 0.89% | 1.39% | +5.1% | Q2 2013 | |
| $87.8M | 0.88% | 1.29% | +27.6% | Q2 2022 | |
| $87.7M | 0.87% | 2.22% | +7.1% | Q2 2013 | |
| $83.5M | 0.83% | 3.65% | +3.2% | Q2 2013 | |
| $77.5M | 0.77% | 1.63% | +0.8% | Q2 2013 | |
| $76.7M | 0.76% | 1.41% | +0.5% | Q1 2020 | |
| $76.7M | 0.76% | 0.74% | -26.3% | Q2 2013 | |
| $73.6M | 0.73% | 7.22% | +3.3% | Q2 2021 | |
| $71.8M | 0.72% | 1.32% | -2.3% | Q2 2020 | |
| $70.2M | 0.70% | 0.89% | -3.2% | Q2 2016 | |
| $69.6M | 0.69% | 1.89% | -14.4% | Q2 2013 | |
| $68.6M | 0.68% | 0.80% | +0.8% | Q4 2015 | |
| $67.3M | 0.67% | 1.11% | -0.5% | Q1 2019 | |
| $66.5M | 0.66% | 0.87% | +5.2% | Q2 2013 | |
| $66.5M | 0.66% | 2.00% | +4.3% | Q3 2022 | |
| $64.7M | 0.65% | 0.97% | -29.2% | Q1 2014 | |
| $62.7M | 0.63% | 0.98% | +1.6% | Q2 2013 | |
| $62.6M | 0.62% | 2.78% | +8.6% | Q1 2017 | |
| $59.5M | 0.59% | 0.95% | +0.4% | Q3 2015 | |
| INGVTIngevity Corp | $57M | 0.57% | 2.86% | -6.1% | Q1 2017 |
| $55.2M | 0.55% | 2.57% | -7.6% | Q2 2020 | |
| $54.3M | 0.54% | 1.14% | -1.9% | Q2 2020 | |
| $53.5M | 0.53% | 1.89% | -10.6% | Q2 2013 | |
| $52.6M | 0.52% | Not reported | +1.0% | Q2 2013 | |
| $52M | 0.52% | 0.75% | +18.9% | Q3 2022 | |
| $51.6M | 0.51% | 0.40% | +0.4% | Q2 2013 | |
| $50.6M | 0.50% | 2.55% | -2.0% | Q1 2014 | |
| $50.5M | 0.50% | 0.83% | -14.4% | Q4 2020 | |
| $50M | 0.50% | 0.82% | +45.2% | Q2 2013 | |
| $49.1M | 0.49% | 9.38% | +44.1% | Q2 2013 | |
| $48.2M | 0.48% | 4.05% | -5.6% | Q2 2013 | |
| $48.2M | 0.48% | 0.24% | -5.9% | Q2 2023 | |
| $47.7M | 0.48% | 1.96% | +48.0% | Q2 2024 | |
| $47.7M | 0.48% | 1.66% | -0.9% | Q2 2013 | |
| $47.5M | 0.47% | 1.36% | +1.0% | Q2 2013 | |
| $47.4M | 0.47% | 0.63% | +1.8% | Q2 2013 | |
| $47.3M | 0.47% | 1.50% | +15.3% | Q2 2013 | |
| $47.3M | 0.47% | 0.28% | -14.2% | Q4 2022 | |
| $46.8M | 0.47% | 1.02% | +3.0% | Q2 2020 | |
| $46.6M | 0.46% | 1.33% | +12.8% | Q2 2013 | |
| $46.3M | 0.46% | 1.26% | +28.2% | Q2 2013 | |
| $45.8M | 0.46% | 4.00% | -15.3% | Q1 2014 | |
| $45.6M | 0.45% | 2.15% | -5.7% | Q2 2013 | |
| $44.8M | 0.45% | 1.18% | -8.3% | Q4 2013 | |
| $44.6M | 0.44% | 0.75% | -7.2% | Q2 2013 | |
| $44.4M | 0.44% | 0.30% | -13.0% | Q2 2013 | |
| $43.6M | 0.44% | 0.63% | +28.6% | Q2 2013 | |
Premium opens every quarter this fund has filed